A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery.

In vivo electroporation is an appealing method to deliver nucleic acid into living tissues, but the clinical application of such a method was limited due to severe tissue damage and poor coverage of the tissue surface. Here we present the validation of a novel flexible microneedle array electrode (MNAE) chip, in which the microneedle array and the flexible substrate are integrated together to simultaneously facilitate low-voltage electroporation and accomplish good coverage of the tissue surface. The efficient delivery of both DNA and siRNA was demonstrated on mice. Upon penetrating the high-resistance stratum corneum, the electroporation voltage was reduced to about 35 V, which was generally recognized safe for humans. Also, a pathological analysis of the microneedle-electroporated tissues was carried out to thoroughly assess the skin damage, which is an important consideration in pre-clinical studies of electroporation devices. This MNAE constitutes a novel way of in vivo delivery of siRNA and DNA to certain tissues or organs with satisfactory efficiency and good adaptation to the tissue surface profile as well as minimum tissue damage, thus avoiding the disadvantages of existing electroporation methods.

[1]  Daniel G. Anderson,et al.  Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice , 2014, Nature Communications.

[2]  V. Shoshan-Barmatz,et al.  Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo , 2014, Molecular therapy. Nucleic acids.

[3]  Zhihong Li,et al.  An electroporation chip based on flexible microneedle array for in vivo nucleic acid delivery , 2014, 2014 IEEE 27th International Conference on Micro Electro Mechanical Systems (MEMS).

[4]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[5]  H. Harashima,et al.  Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Ernst Wagner,et al.  Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Thakur Raghu Raj Singh,et al.  Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery , 2012, Advanced functional materials.

[8]  Jung-Hwan Park,et al.  Intracellular protein delivery and gene transfection by electroporation using a microneedle electrode array. , 2012, Small.

[9]  Daniel G. Anderson,et al.  Action and reaction: the biological response to siRNA and its delivery vehicles. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  E. Hur,et al.  Genetic dissection of axon regeneration via in vivo electroporation of adult mouse sensory neurons , 2011, Nature communications.

[11]  J. Burnett,et al.  Current progress of siRNA/shRNA therapeutics in clinical trials , 2011, Biotechnology journal.

[12]  Zhihong Li,et al.  A parylene-based flexible electroporation chip applicable for in vivo gene and siRNA delivery , 2011, 2011 16th International Solid-State Sensors, Actuators and Microsystems Conference.

[13]  M. Prausnitz,et al.  Dissolving microneedle patch for transdermal delivery of human growth hormone. , 2011, Small.

[14]  Yong-Kyu Yoon,et al.  An electrically active microneedle array for electroporation , 2010, Biomedical microdevices.

[15]  D. Wells.  Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo , 2010, Cell Biology and Toxicology.

[16]  R. Heller,et al.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  Damijan Miklavcic,et al.  Non invasive contact electrodes for in vivo localized cutaneous electropulsation and associated drug and nucleic acid delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[19]  Federica Cavallo,et al.  Vaccines for tumour prevention , 2006, Nature Reviews Cancer.

[20]  M. Tangney,et al.  Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. , 2006, Cancer letters.

[21]  K. Sugibayashi,et al.  Effect of electric field on the enhanced skin permeation of drugs by electroporation. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[23]  Molecular therapy , 2002, Journal of the Neurological Sciences.

[24]  E. Signori,et al.  Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage , 2001, Gene Therapy.

[25]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo , 1998, Nature Biotechnology.

[26]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[27]  M. Locniskar,et al.  Serum lymphocytotoxic activity in leprosy. , 1989, Clinical and experimental immunology.

[28]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.

[29]  W. Marsden.  I and J , 2012 .

[30]  C. Holding.  Lab on a chip , 2004, Genome Biology.

[31]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[32]  and as an in , 2022 .